The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy

Journal Title: Pharmacology and Clinical Pharmacy Research - Year 2018, Vol 3, Issue 1

Abstract

Patients with hyperlipidaemia is at increased risk of developing atherosclerotic cardiovascular disease (ASCVD). The use of appropriate statin therapy is important to obtain optimal health outcomes. However, there was limited information regarding the risk of ASCVD among Indonesian hyperlipidaemia population and the appropriateness of statin therapy given to these patients. This study aimed to assess the ASCVD risks among the patients and evaluate the use of statin therapy at hospitalized hyperlidaemia patients. This cross sectional study used medical records as data source. This study was conducted at one hospital in Pontianak, Indonesia during Januari-June 2017. We included 50 subjects. The 10-year risk of ASCVD was assessed using ASCVD pooled cohort risk assessment equation (PCRAE). The results showed that 66% of the included subjects had a relatively high risk of developing ASCVD. Subjects with high risk of ASCVD received inappropriate statin therapy. High intensity statin should be given to these patients. In conclusion, large proportion of the subjects were at high risk of developing ASCVD. Nevertheless, inappropriate statin therapy were given to these patients. Improvement in medication practice should be done to prevent complication and increase quality of health outcomes.

Authors and Affiliations

Maharani F. Iskandar, Nurmainah Nurmainah, Ressi Susanti

Keywords

Related Articles

Comparison of Effectiveness between Combination of Beta-Lactam with Azyhtromycin or Levofloxacin for Adult Pneumonia Patients

Treatment for pneumonia has always been a challenge due to the difficulties in diagnosis and the growing incidence of antibiotic resistance. Beta-lactam antibiotics are the first line treatment for pneumonia. The combina...

Drug Related Problems of Diabetic Nephropathy Patients in a Tertiary Hospital in Malaysia

Patients with diabetic nephropathy (DN) are particularly vulnerable to drug related problems (DRPs) due to complex medication regimen and renal dysfunction. However, there was limited information regarding prevalence of...

Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure

Lisinopril (angiotensin converting enzyme inhibitor) and valsartan (angiotensin II receptor blocker) are the first-line treatment for patients with congestive heart failure (CHF) These two drugs potentially cause side ef...

Secondary Metabolites and Antioxidant Activity of Methanol Extract of Castanopsis costata Leaves

Castanopsis costata (C.costata) leaves were empirically used by people in North Sumatera, Indonesia, as an antioxidant dietary supplement. However, its pharmacological effect has not been scientifically explored. The pur...

Physicochemical Properties of Phosphate Pregelatinized Musa balbisiana Starch as Pharmaceutical Excipient

Starch is among the important pharmaceutical excipient, which is particularly used as filler in the tablet formulation and suspending agent. Starch from natural source has a potential to be developed as pharmaceutical ex...

Download PDF file
  • EP ID EP353391
  • DOI -
  • Views 99
  • Downloads 0

How To Cite

Maharani F. Iskandar, Nurmainah Nurmainah, Ressi Susanti (2018). The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy. Pharmacology and Clinical Pharmacy Research, 3(1), 21-25. https://europub.co.uk/articles/-A-353391